Svk Laboratories Private Limited - Due diligence report

A 360° intelligence report on Svk Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

2011-05-10 Hyderabad, Telangana Active Unlisted Active Compliant
Share
Connect MCP
SL Svk Laboratories Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Svk Laboratories Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Svk Laboratories Private Limited is assessed as Low Risk with a Trust Score of 77/100. Svk Laboratories Private Limited is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 11 Aug 2026 from the latest processed filings. Svk Laboratories Private Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
30/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 30/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 2 open (8.40 cr) · 2 satisfied (10.51 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others4 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
VANAJA PAVULURI 01234567 Director 01/04/2018 6 yrs Approved
VINOD KUMAR PAAVULURI 01234567 Director 01/04/2018 6 yrs Approved
KRISHNA REDDY YEDLA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • VINOD KUMAR PAAVULURI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment55/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 8.40 cr already registered.
  • Compliance record supports lending.
Investor view66/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
25 Sep 2025
Director appointed
KRISHNA REDDY YEDLA (Director)
31 Mar 2025
Latest balance sheet
Filed with ROC
23 Mar 2023
Director ceased
VEERA VENKATA SATYA VARA PRASAD VEGT
10 Mar 2022
Charge created
Others - 30.00 Lakh
06 Mar 2022
Director ceased
KRISHNA KUMAR RAMACHANDRULA
06 Aug 2021
Director ceased
SREEPATHIRAO RAO KILARI
31 Mar 2021
Share transfer (FY 2021)
360000.00000000 shares to VINOD KUMAR PAVULURI
15 Sep 2020
Director ceased
JAYA BHANU VENKATA NAGESWARA RAO NALLA
04 Sep 2019
Charge satisfied
Others
13 Aug 2019
Director appointed
VINOD KUMAR PAAVULURI (Director)
02 Aug 2019
Charge created
Others - 8.10 cr
31 Mar 2019
Share transfer (FY 2019)
110000.00000000 shares to VANAJA PAVULURI
Share transfer (FY 2019)
435000.00000000 shares to VANAJA PAVULURI
17 Feb 2018
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Mia Plasticizer And Allied Products Private Limited U74899DL1987PTC027615 Delhi, Delhi, India
Shakti Resin Private Limited U24231HR2015PTC055912 Faridabad, Haryana, India
Nitin Dye Chem U24100MH1976PTC019191 Mumbai, Maharashtra, India
Farmherbs U24233KL2006PTC020054 Koothattukulam, Kerala, India
Khilari Lifesciences Private Limited U24302MH2020PTC351176 Khargar, Maharashtra, India
Cilantro Chemicals Private Limited U24297MH2015PTC265845 Thane, Maharashtra, India
Rincon Pharmaceuticals U24232TG2009PTC062946 Hyderabad, Telangana, India
Agma Packaging Private Limited U21022TN2004PTC054914 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Svk Laboratories Private Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Svk Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 30/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Svk Laboratories Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Svk Laboratories Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Svk Laboratories Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Svk Laboratories Private Limited an active company?

Svk Laboratories Private Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Svk Laboratories Private Limited financially healthy?

Svk Laboratories Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Svk Laboratories Private Limited?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Svk Laboratories Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Svk Laboratories Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Svk Laboratories Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Svk Laboratories Private Limited?

Its Credit Risk Score is 30/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.